Inhibition of EGF Uptake by Nephrotoxic Antisense Drugs In Vitro and Implications for Preclinical Safety Profiling.
about
Managing the sequence-specificity of antisense oligonucleotides in drug discovery.MicroRNAs and toxicology: A love marriage.Assessing single-stranded oligonucleotide drug-induced effects in vitro reveals key risk factors for thrombocytopenia.A Sensitive In Vitro Approach to Assess the Hybridization-Dependent Toxic Potential of High Affinity Gapmer Oligonucleotides.Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In Vivo.
P2860
Inhibition of EGF Uptake by Nephrotoxic Antisense Drugs In Vitro and Implications for Preclinical Safety Profiling.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inhibition of EGF Uptake by Ne ...... Preclinical Safety Profiling.
@en
Inhibition of EGF Uptake by Ne ...... Preclinical Safety Profiling.
@nl
type
label
Inhibition of EGF Uptake by Ne ...... Preclinical Safety Profiling.
@en
Inhibition of EGF Uptake by Ne ...... Preclinical Safety Profiling.
@nl
prefLabel
Inhibition of EGF Uptake by Ne ...... Preclinical Safety Profiling.
@en
Inhibition of EGF Uptake by Ne ...... Preclinical Safety Profiling.
@nl
P2093
P2860
P1476
Inhibition of EGF Uptake by Ne ...... Preclinical Safety Profiling.
@en
P2093
Adrian B Roth
Andreas Maunz
Annamaria Braendli-Baiocco
Annie Moisan
Blandine Avignon
Fethallah Benmansour
Franz Schuler
Jitao David Zhang
Kamille Dumong Erichsen
Marcel Gubler
P2860
P304
P356
10.1016/J.OMTN.2016.11.006
P577
2016-12-10T00:00:00Z